Spirometer Market By Product (Table-Top Spirometer, Hand-Held Spirometer, Desktop (Pc) Spirometer), By Technology (Volume Measurement Spirometer), By Application (Diagnostic, Therapeutic), Industry Size, Growth, Share And Forecast To 2022
Key Findings
The global spirometer market has generated revenue of approx. $533 million in 2015 and is anticipated to generate approx. $1039 million in 2022 growing at a CAGR of approx. 10%. The drivers which grow the market are the rising aging population, growing incidences of chronic diseases, and advancement of technology in the field of respiratory care devices. Due to increase in the number of cases such as asthma and multiple sclerosis and chronic diseases like cancer and diabetes, there has been an increase in the demand of diagnostic devices globally which in turn has accelerated the market of spirometers worldwide. According to world health organization, in 2015 it was observed that in U.S. more than 1658370 new cancer cases were diagnosed among which more than 848200 were male cancer cases and 810170 female cancer cases. It was also seen that more than 589430 deaths had occurred due to cancer, among which 312150 were males and 277280 females. In India, in 2015 more than 666,563 deaths were reported due to cancer. Lung cancer is the most common type of cancer among men’s globally. In 2014 more than 1.3 million cancer cases were reported among men worldwide. Breast cancer is one of the most common types of cancer among women’s, both in developed and developing countries. It was observed that in 2014, globally, more than 1.7 million new breast cancer cases among women were diagnosed. Due to increasing incidences of chronic disease and growing number of deaths due to it, there has been an increase in the demand of medical checkup or diagnostics which in turn increases the market of spirometer. The growing geriatric population worldwide is the major factor which increases the market of spirometer globally. In Germany, only 13 percent population is 14 years or above, rest only 21 percent of total Germany’s population is of 65 years and above. Hence, aging population is the major cause of increase for spirometer market globally.
Market Segment Insight
The global spirometer market is segmented on the basis of product, technology, end users and application. On the basis of product, the market is segmented as table-top spirometer, hand-held spirometer and desktop (PC) spirometer. The table-top spirometer is a highly portable and a new-generation microlab spirometer, which is developed for the professionals. This device uses high digital volume transducer technology, which makes it easy to measure very low flow rates in patients with chronic obstructive pulmonary diseases. The handheld spirometer having high-definition backlit display, measures and displays the patient's forced vital capacity. The increasing demand for diagnostic products helps in boosting the market of spirometer globally. On the basis of technology, the market is segmented as volume measurement spirometer, flow measurement spirometer and peak flow meter. On the basis of application, the market is segmented as diagnostic and therapeutic. On the basis of end users the market is segmented as hospital, clinic, and homecare.
Regional Insight
The report also contains the major regions including North America, Europe, Asia Pacific, and Rest of the World. North America has the highest market share of spirometer followed by Europe and Asia Pacific. Asia Pacific region is anticipated to grow rapidly because of the increasing cases of respiratory diseases. In North America, especially in US, Canada and Mexico the increasing cases of respiratory diseases and regulations to monitor patient’s respiratory status are accelerating the market of spirometers. In addition to this, growing awareness about the diseases and availability of various therapeutic and monitoring devices is fueling the growth of market. Europe has the second largest share in spirometers market globally. Economic crisis, increase in healthcare costs, and uneven reimbursement policies across different countries in Europe poses as major hinderances for the market.
Competitive Insights
Some of the major market players are CareFusion, Cosmed, Futuremed,Jones Medical Instrument Company, Medical International Research, Midmark Corp., NDD Medical Technologies, Inc., Nihon Kohden Corporation, MGC Diagnostics Corporation,Philips Healthcare, Schiller, Smiths Medical ASD, Inc., Vitalograph, Welch Allyn, Miami-Luken , Inc.,Vitalograph, Welch Allyn, Miami-Luken , Inc.etc. Acquisition, mergers and expansions are the key strategies adopted by the market players to sustain in the market. For example, in 2015 Becton, Dickinson and Company announced that it has completed its acquisition of CareFusion Corporation. Similarly in 2014, Philips healthcare announced that it has completed the acquisition of Volcano Corporation.
CHAP 1. METHODOLOGY & SCOPE 11
1.1. RESEARCH METHODOLOGY 11
1.2. RESEARCH SCOPE & ASSUMPTIONS 11
1.3. LIST OF DATA SOURCES 11
CHAP 2. EXECUTIVE SUMMARY 12
2.1. GLOBAL SPIROMETER SUMMARY & KEY BUYING CRITERIA 12
2.2. GLOBAL SPIROMETER OUTLOOK 12
2.3. MARKET SEGMENTATION ANALYSIS 12
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 12
2.5. GLOBAL SPIROMETER VALUE CHAIN ANALYSIS 12
2.6. VENDOR LANDSCAPE 12
CHAP 3. GLOBAL SPIROMETER DETERMINENTS 13
3.1. MARKET DRIVER ANALYSIS 13
3.2. MARKET RESTRAINT ANALYSIS 13
3.3. KEY OPPORTUNITIES 13
3.4. CHALLENGES 13
CHAP 4. INDUSTRY ANALYSIS 14
4.1. GLOBAL SPIROMETER – PORTER’S FIVE FORCE MODEL 14
4.2. GLOBAL SPIROMETER – PESTEL ANALYSIS 14
4.3. GLOBAL SPIROMETER – GAP ANALYSIS 14
CHAP 5. GLOBAL SPIROMETERS MARKET BY PRODUCT 2012-2022 ($ BILLION) 15
5.1. GLOBAL SPIROMETERS MARKET BY TABLE-TOP SPIROMETER 2012-2022 ($ BILLIONS) 15
5.2. GLOBAL SPIROMETERS MARKET BY HAND-HELD SPIROMETER 2012-2022 ($ BILLIONS) 15
5.3. GLOBAL SPIROMETERS MARKET BY DESKTOP (PC) SPIROMETER 2012-2022 ($ BILLIONS) 15
CHAP 6. GLOBAL SPIROMETERS MARKET BY TECHNOLOGY 2012-2022 ($ BILLION) 16
6.1. GLOBAL SPIROMETERS MARKET BY VOLUME MEASUREMENT SPIROMETER 2012-2022 ($ BILLION) 16
CHAP 7. GLOBAL SPIROMETERS MARKET BY APPLICATION 2012-2022 ($ BILLION) 17
7.1. GLOBAL SPIROMETERS MARKET BY DIAGNOSTIC 2012-2022 ($ BILLION) 17
7.2. GLOBAL SPIROMETERS MARKET BY THERAPEUTIC 2012-2022 ($ BILLION) 17
CHAP 8. GLOBAL SPIROMETERS MARKET END-USERS 2012-2022 ($ BILLION) 18
8.1. GLOBAL SPIROMETERS MARKET HOSPITAL 2012-2022 ($ BILLION) 18
8.2. GLOBAL SPIROMETERS MARKET CLINIC 2012-2022 ($ BILLION) 18
8.3. GLOBAL SPIROMETERS MARKET HOMECARE 2012-2022 ($ BILLION) 18
CHAP 9. GLOBAL SPIROMETER REGIONAL OUTLOOK 2012-2022 ($ BILLION) 19
9.1. GLOBAL SPIROMETER MARKET BY REGION 2012-2022 ($ BILLION) 19
9.2. NORTH AMERICA 19
9.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
9.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
9.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
9.2.3.1. U.S. 19
9.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
9.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
9.2.3.2. CANADA 19
9.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
9.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
9.3. EUROPE 19
9.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
9.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
9.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
9.3.3.1. GERMANY 19
9.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
9.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
9.3.3.2. UK 20
9.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
9.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
9.3.3.3. FRANCE 20
9.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
9.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
9.3.3.4. SPAIN 20
9.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
9.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
9.3.3.5. REST OF EUROPE 20
9.3.3.5.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($ BILLION) 21
9.3.3.5.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($ BILLION) 21
9.4. ASIA PACIFIC 21
9.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
9.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 21
9.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
9.4.3.1. CHINA 21
9.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
9.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
9.4.3.2. INDIA 21
9.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
9.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
9.4.3.3. JAPAN 21
9.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
9.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 21
9.4.3.4. OTHERS 21
9.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($ BILLION) 22
9.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($ BILLION) 22
9.5. MIDDLE EAST & AFRICA 22
9.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
9.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
9.6. LATIN AMERICA 22
9.6.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
9.6.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
9.6.2.1. BRAZIL 22
9.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 22
9.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 22
CHAP 10. COMPETITIVE LANDSCAPE 23
10.1. CAREFUSION 24
10.1.1. COMPANY OVERVIEW 24
10.1.2. SCOT ANALYSIS 24
10.1.3. PRODUCT BENCHMARKING 24
10.1.4. STRATEGIC INITIATIVES 24
10.2. COSMED 24
10.2.1. COMPANY OVERVIEW 24
10.2.2. SCOT ANALYSIS 24
10.2.3. PRODUCT BENCHMARKING 24
10.2.4. STRATEGIC INITIATIVES 24
10.3. FUTUREMED 24
10.3.1. COMPANY OVERVIEW 24
10.3.2. SCOT ANALYSIS 24
10.3.3. PRODUCT BENCHMARKING 24
10.3.4. STRATEGIC INITIATIVES 24
10.4. JONES MEDICAL INSTRUMENT COMPANY 24
10.4.1. COMPANY OVERVIEW 24
10.4.2. SCOT ANALYSIS 24
10.4.3. PRODUCT BENCHMARKING 24
10.4.4. STRATEGIC INITIATIVES 24
10.5. MEDICAL INTERNATIONAL RESEARCH 24
10.5.1. COMPANY OVERVIEW 24
10.5.2. SCOT ANALYSIS 24
10.5.3. PRODUCT BENCHMARKING 24
10.5.4. STRATEGIC INITIATIVES 24
10.6. MGC DIAGNOSTICS CORPORATION 24
10.6.1. COMPANY OVERVIEW 24
10.6.2. SCOT ANALYSIS 25
10.6.3. PRODUCT BENCHMARKING 25
10.6.4. STRATEGIC INITIATIVES 25
10.7. MIDMARK CORP. 25
10.7.1. COMPANY OVERVIEW 25
10.7.2. SCOT ANALYSIS 25
10.7.3. PRODUCT BENCHMARKING 25
10.7.4. STRATEGIC INITIATIVES 25
10.8. NDD MEDICAL TECHNOLOGIES, INC. 25
10.8.1. COMPANY OVERVIEW 25
10.8.2. SCOT ANALYSIS 25
10.8.3. PRODUCT BENCHMARKING 25
10.8.4. STRATEGIC INITIATIVES 25
10.9. NIHON KOHDEN CORPORATION 25
10.9.1. COMPANY OVERVIEW 25
10.9.2. SCOT ANALYSIS 25
10.9.3. PRODUCT BENCHMARKING 25
10.9.4. STRATEGIC INITIATIVES 25
10.10. PHILIPS HEALTHCARE 25
10.10.1. COMPANY OVERVIEW 25
10.10.2. SCOT ANALYSIS 25
10.10.3. PRODUCT BENCHMARKING 25
10.10.4. STRATEGIC INITIATIVES 25
10.11. SCHILLER 25
10.11.1. COMPANY OVERVIEW 25
10.11.2. SCOT ANALYSIS 25
10.11.3. PRODUCT BENCHMARKING 25
10.11.4. STRATEGIC INITIATIVES 26
10.12. SMITHS MEDICAL ASD, INC. 26
10.12.1. COMPANY OVERVIEW 26
10.12.2. SCOT ANALYSIS 26
10.12.3. PRODUCT BENCHMARKING 26
10.12.4. STRATEGIC INITIATIVES 26
10.13. VITALOGRAPH 26
10.13.1. COMPANY OVERVIEW 26
10.13.2. SCOT ANALYSIS 26
10.13.3. PRODUCT BENCHMARKING 26
10.13.4. STRATEGIC INITIATIVES 26
10.14. WELCH ALLYN 26
10.14.1. COMPANY OVERVIEW 26
10.14.2. SCOT ANALYSIS 26
10.14.3. PRODUCT BENCHMARKING 26
10.14.4. STRATEGIC INITIATIVES 26
10.15. MIAMI-LUKEN , INC. 26
10.15.1. COMPANY OVERVIEW 26
10.15.2. SCOT ANALYSIS 26
10.15.3. PRODUCT BENCHMARKING 26
10.15.4. STRATEGIC INITIATIVES 26
TABLE 1 GLOBAL SPIROMETERS MARKET TYPES 2012-2022 ($ BILLION) 27
TABLE 2 GLOBAL SPIROMETERS MARKET RECOMBINANT HUMAN PROTEINS DRUGS 2012-2022 ($ BILLION) 27
TABLE 3 GLOBAL SPIROMETERS MARKET MONOCLONAL ANTIBODIES 2012-2022 ($ BILLION) 27
TABLE 4 GLOBAL SPIROMETERS MARKET RITUXAN 2012-2022 ($ BILLION) 27
TABLE 5 GLOBAL SPIROMETERS MARKET ERBITUX 2012-2022 ($ BILLION) 27
TABLE 6 GLOBAL SPIROMETERS MARKET BACTARIAL PROTEIN 2012-2022 ($ BILLION) 27
TABLE 7 GLOBAL SPIROMETERS MARKET OTHERS 2012-2022 ($ BILLION) 27
TABLE 8 GLOBAL SPIROMETERS MARKET TECHNOLOGY 2012-2022 ($ BILLION) 27
TABLE 9 GLOBAL SPIROMETERS MARKET RATIONAL PROTEIN DESIGN 2012-2022 ($ BILLION) 27
TABLE 10 GLOBAL SPIROMETERS MARKET IRRATIONAL PROTEIN DESIGN 2012-2022 ($ BILLION) 27
TABLE 11 GLOBAL SPIROMETERS MARKET PRODUCT 2012-2022 ($ BILLION) 27
TABLE 12 GLOBAL SPIROMETERS MARKET INSTRUMENTS 2012-2022 ($ BILLION) 27
TABLE 13 GLOBAL SPIROMETERS MARKET REAGENTS 2012-2022 ($ BILLION) 27
TABLE 14 GLOBAL SPIROMETERS MARKET SERVICES AND SOFTWARE 2012-2022 ($ BILLION) 28
TABLE 15 GLOBAL SPIROMETERS MARKET END-USERS 2012-2022 ($ BILLION) 28
TABLE 16 GLOBAL SPIROMETERS MARKET ACADEMIC RESEARCH INSTITUTES 2012-2022 ($ BILLION) 28
TABLE 17 GLOBAL SPIROMETERS MARKET CONTRACT RESEARCH ORGANIZATIONS 2012-2022 ($ BILLION) 28
TABLE 18 GLOBAL SPIROMETERS MARKET PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 2012-2022 ($ BILLION) 28
TABLE 19 NORTH AMERICA SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 28
TABLE 20 NORTH AMERICA SPIROMETER MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 28
TABLE 21 NORTH AMERICA SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 28
TABLE 22 U.S. SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 28
TABLE 23 U.S. SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 28
TABLE 24 CANADA SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 28
TABLE 25 CANADA SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 –2022 ($ BILLION) 28
TABLE 26 CANADA SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 28
TABLE 27 EUROPE SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 28
TABLE 28 EUROPE SPIROMETER MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 28
TABLE 29 EUROPE SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 28
TABLE 30 GERMANY SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 28
TABLE 31 SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 29
TABLE 32 UK SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 29
TABLE 33 UK SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 29
TABLE 34 ASIA PACIFIC SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 29
TABLE 35 ASIA PACIFIC SPIROMETER MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ BILLION) 29
TABLE 36 ASIA PACIFIC SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 29
TABLE 37 CHINA SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 29
TABLE 38 CHINA SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 29
TABLE 39 INDIA SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 29
TABLE 40 INDIA SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 29
TABLE 41 JAPAN SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 29
TABLE 42 JAPAN SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 29
TABLE 43 MIDDLE EAST & AFRICA SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 29
TABLE 44 MIDDLE EAST & AFRICA SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 29
TABLE 45 CENTRAL & SOUTH AMERICA SPIROMETER MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ BILLION) 29
TABLE 46 CENTRAL & SOUTH AMERICA SPIROMETER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ BILLION) 29
FIGURE 1 MARKET SHARE BY REGIONS 30
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 30
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)